Investigating the effect of ginger capsules on blood pressure.
Phase 3
- Conditions
- Prehypertension.
- Registration Number
- IRCT20220821055757N1
- Lead Sponsor
- Khoram-Abad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
Patients who have received a diagnosis of hypertension within the maximum last three months.
Patient consent to enter the study.
The age of the patients is between 30 and 70 years.
Exclusion Criteria
Patients with diabetes.
Patients with high blood pressure.
Patients with blood disorders.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Systolic and diastolic blood pressure (main variable). Timepoint: At the beginning of the study (before intervention) and 4, 8 weeks after the start of taking ginger capsules. Method of measurement: Mercury sphygmomanometer.;Cholesterol. Timepoint: At the beginning of the study (before intervention) and 4, 8 weeks after the start of taking ginger capsules. Method of measurement: Chemistry Analyzer.;Triglycerides. Timepoint: At the beginning of the study (before intervention) and 4, 8 weeks after the start of taking ginger capsules. Method of measurement: Chemistry Analyzer.;Low Density Lipoprotein (LDL). Timepoint: At the beginning of the study (before intervention) and 4, 8 weeks after the start of taking ginger capsules. Method of measurement: Chemistry Analyzer.;Nitric oxide metabolites. Timepoint: At the beginning of the study (before intervention) and 4, 8 weeks after the start of taking ginger capsules. Method of measurement: Nitric oxide assay kit.
- Secondary Outcome Measures
Name Time Method